Mitocin, commonly known by its generic name Mitomycin, is a chemotherapy medication used in the treatment of various types of cancer, including stomach, pancreas, bladder, and breast cancers. It belongs to a class of drugs known as antineoplastic antibiotics, which work by interfering with the DNA synthesis of cancer cells, thereby inhibiting their growth and proliferation. Mitocin is often administered intravenously, and its usage and dosage depend on the type of cancer being treated, the patient's health status, and response to therapy. Like other chemotherapy drugs, Mitocin can have significant side effects, including nausea, vomiting, loss of appetite, and a decrease in blood cell counts, which can increase the risk of infection and bleeding. Its use requires careful monitoring by healthcare professionals to manage its effects and adjust treatment as necessary.